Sertraline Krka 50 mg film-coated tablets

国家: 爱尔兰

语言: 英文

来源: HPRA (Health Products Regulatory Authority)

现在购买

资料单张 资料单张 (PIL)
03-12-2021
产品特点 产品特点 (SPC)
03-12-2021

有效成分:

Sertraline

可用日期:

KRKA, d.d., Novo mesto

ATC代码:

N06AB; N06AB06

INN(国际名称):

Sertraline

剂量:

50 milligram(s)

药物剂型:

Film-coated tablet

处方类型:

Product subject to prescription which may not be renewed (A)

治疗领域:

Selective serotonin reuptake inhibitors; sertraline

授权状态:

Marketed

授权日期:

2011-07-22

资料单张

                                PACKAGE LEAFLET: INFORMATION FOR THE PATIENT
SERTRALINE KRKA 50 MG FILM-COATED TABLETS
SERTRALINE KRKA 100 MG FILM-COATED TABLETS
sertraline
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE BECAUSE IT CONTAINS
IMPORTANT INFORMATION FOR YOU.
-
Keep this leaflet. You may need to read it again.
-
If you have any further questions, ask your doctor or pharmacist.
-
This medicine has been prescribed for you only. Do not pass it on to
others. It may harm them,
even if their signs of illness are the same as yours.
-
If you get any side effects, talk to your doctor or pharmacist. This
includes any possible side
effects not listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET
:
1.
What Sertraline Krka is and what it is used for
2.
What you need to know before you take Sertraline Krka
3.
How to take Sertraline Krka
4.
Possible side effects
5.
How to store Sertraline Krka
6.
Contents of the pack and other information
1.
WHAT SERTRALINE KRKA IS AND WHAT IT IS USED FOR
Sertraline Krka contains the active ingredient sertraline. Sertraline
is one of a group of medicines
called Selective Serotonin Re-uptake Inhibitors (SSRIs); these
medicines are used to treat depression
and or anxiety disorders.
SERTRALINE KRKA CAN BE USED TO TREAT:
-
Depression and prevention of recurrence of depression (in adults).
-
Social anxiety disorder (in adults).
-
Post traumatic stress disorder (PTSD) (in adults).
-
Panic disorder (in adults).
-
Obsessive compulsive disorder (OCD) (in adults and children and
adolescents aged 6-17 years
old).
Depression is a clinical illness with symptoms like feeling sad,
unable to sleep properly or to enjoy
life as you used to.
OCD and Panic disorders are illnesses linked to anxiety with symptoms
like being constantly
troubled by persistent ideas (obsessions) that make you carry out
repetitive rituals (compulsions).
PTSD is a condition that can occur after a very emotionally traumatic
experience and has some
symptoms that are similar to depression and anxiety. Social anxiety
disorder 
                                
                                阅读完整的文件
                                
                            

产品特点

                                Health Products Regulatory Authority
02 December 2021
CRN00CLNV
Page 1 of 15
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT
Sertraline Krka 50 mg film-coated tablets
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each film-coated tablet contains 50 mg sertraline as sertraline
hydrochloride.
For the full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Film-coated tablet.
White, oval, slightly biconvex film-coated tablets with score on one
side and S3sign on the opposite side. The tablet can be
divided into equal doses.
4 CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
Sertraline is indicated for the treatment of:
Major depressive episodes. Prevention of recurrence of major
depressive episodes.
Panic disorder, with or without agoraphobia.
Obsessive compulsive disorder (OCD) in adults and paediatric patients
aged 6-17 years.
Social anxiety disorder.
Post traumatic stress disorder (PTSD)
4.2 POSOLOGY AND METHOD OF ADMINISTRATION
Posology
_Initial treatment_
_Depression and OCD_
Sertraline treatment should be started at a dose of 50 mg/day.
_ _
_Panic Disorder, PTSD, and Social Anxiety Disorder_
Therapy should be initiated at 25 mg/day. After one week, the dose
should be increased to 50 mg once daily. This dosage
regimen has been shown to reduce the frequency of early treatment
emergent side effects characteristic of panic disorder.
_Titration_
_Depression, OCD, Panic Disorder, Social Anxiety Disorder and PTSD_
Patients not responding to a 50 mg dose may benefit from dose
increases. Dose changes should be made in steps of 50 mg at
intervals of at least one week, up to a maximum of 200 mg/day. Changes
in dose should not be made more frequently than
once per week given the 24-hour elimination half life of sertraline.
The onset of therapeutic effect may be seen within 7 days. However,
longer periods are usually necessary to demonstrate
therapeutic response, especially in OCD.
_Maintenance_
Dosage during long‑term therapy should be kept at the lowest
effective level, with subsequent adjustmen
                                
                                阅读完整的文件
                                
                            

搜索与此产品相关的警报